Home / World Marketplace / Global Corporate Affairs / Archive by category Survey and Research (Page 135)

Archive by category Survey and Research

PwC: CEO Confidence Rises Despite New Risks and Uncertainty

DAVOS, Switzerland, Jan. 16 (Korea Bizwire) — While CEOs around the world feel they have plenty to worry about in the year ahead, their confidence in their own growth prospects and their outlook for the global economy are back on the rise. Graphics accompanying this announcement are available at http://www.globenewswire.com/NewsRoom/AttachmentNg/77eaac3e-f05b-4fc2-b82a-ee926f9078e1 http://www.globenewswire.com/NewsRoom/AttachmentNg/f27a6ebc-f247-494a-bb07-e4507f11b772 In PwC’s 20th annual survey [...]

IHS Markit Names BroadSoft The UCaaS Platform Global Market Share Leader

GAITHERSBURG, Md., Jan. 16 (Korea Bizwire) — BroadSoft, Inc. (NASDAQ:BSFT), has been identified by IHS Markit as the global Unified Communications as a Service (UCaaS) platform leader, with 38% of the total worldwide UCaaS seats running on its platforms, as of the second quarter of 2016. According to the IHS study, the BroadSoft UCaaS global [...]

RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phase III Study for H. pylori Infection

TEL-AVIV, Israel, Jan. 10 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced first dosing in a three-way crossover pharmacokinetic (PK) study with RHB-105 [...]

PwC’s Strategy& Introduces New Book “Fit for Growth: A Guide to Strategic Cost Cutting, Restructuring, and Renewal”

NEW YORK, Jan. 10 (Korea Bizwire) — The New Year holds one thing for certain: uncertainty. As business leaders find themselves plagued by sluggish growth, increasing geopolitical tension, heightened regulatory scrutiny, and the rapid pace of digital change, 2017 is gearing up to be “the year of the question mark.” How can businesses achieve and [...]

Radware Research Finds Data Loss Is Top Cyber-Attack Concern

MAHWAH, N.J., Jan. 10 (Korea Bizwire) — Radware® (NASDAQ:RDWR), a leading provider of cyber security and application delivery solutions ensuring the digital user experience for applications in virtual, cloud, and software-defined data centers, has found that hackers and companies agree on one thing: Data is lucrative. Radware’s Global Application and Network Security Report 2016-2017 revealed [...]

The PrivCo Asia 50: Ranking Asia’s Largest Private Companies

NEW YORK, Dec. 30 (Korea Bizwire) — PrivCo has just released The PrivCo Asia 50: Ranking the Largest Private Companies in Asia by Revenue Report. PrivCo screened through its proprietary Private Company Financial Database with information on over 900,000+ private companies to rank the PrivCo Asia 50, the definitive ranking of the top 50 privately-held companies in [...]

RedHill Biopharma Announces First Patient Dosed in Phase Ib/II Study with YELIVA® for Multiple Myeloma

TEL-AVIV, Israel, Dec. 19 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that the first patients have been screened and a first patient has been [...]

RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn’s Disease

TEL-AVIV, Israel, Dec. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today reported that, following a pre-planned review of safety data from its ongoing Phase III [...]

Only 30% of Subscribers are Aware of Risks Posed by Mobile Network Vulnerabilities

WAKEFIELD, Mass., Dec. 12 (Korea Bizwire) — Research commissioned by Xura, Inc, a leading provider of secure, digital communications services, has revealed the extent to which mobile subscribers are unaware of vulnerabilities in their mobile operator’s network that could lead to their calls or texts being intercepted, so becoming victims of fraud or unauthorized location [...]

RedHill Biopharma Announces Phase IIa 48-Week Final Results Further Supporting Potential of RHB-104 in Multiple Sclerosis

TEL-AVIV, Israel, Dec. 12 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced the top-line final results from its CEASE-MS Phase IIa proof-of-concept (PoC) clinical study [...]